Guided Therapeutics (GTHP) Research & Development (2010 - 2025)
Guided Therapeutics' (GTHP) quarterly Research & Development came in at $127000.0 in Q4 2025, down 9.29% year-on-year from $140000.0 in Q4 2024, and down 6.62% quarter-over-quarter from $136000.0 in Q3 2025.
Guided Therapeutics (GTHP) Research & Development (2010 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Research & Development across 16 years of filings, most recently posting $127000.0 for Q4 2025.
- Research & Development for Q4 2025 came in at $127000.0, down 9.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $470000.0 (down 10.82% YoY), and the FY2025 annual result was $469000.0, down 10.84% from the prior year.
- Research & Development came in at $127000.0 for Q4 2025 at Guided Therapeutics, down from $136000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $222000.0 in Q2 2024 to a low of $7000.0 in Q1 2023.
- The 5-year median for Research & Development is $60000.0 (2023), against an average of $68550.0.
- Peak annual rise in Research & Development reached 762.5% in 2023, while the deepest fall reached 66.67% in 2023.
- Guided Therapeutics' Research & Development stood at $17000.0 in 2021, then surged by 129.41% to $39000.0 in 2022, then surged by 120.51% to $86000.0 in 2023, then surged by 62.79% to $140000.0 in 2024, then slipped by 9.29% to $127000.0 in 2025.
- The last three Research & Development figures came in at $127000.0 (Q4 2025), $136000.0 (Q3 2025), and $133000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 136,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 86,000.00 |
| Sep 30, 2023 | 69,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 16,000.00 |